{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:43:47Z","timestamp":1787003027821,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The genetic bases of mosaic pigmentation disorders have increasingly been identified, but these conditions remain poorly characterised, and their pathophysiology is unclear. Here, we report in four unrelated patients that a recurrent postzygotic mutation in\n                    <jats:italic>GNA13<\/jats:italic>\n                    is responsible for a recognizable syndrome with hypomelanosis of Ito associated with developmental anomalies.\n                    <jats:italic>GNA13<\/jats:italic>\n                    encodes G\u03b1\n                    <jats:sub>13<\/jats:sub>\n                    , a subunit of \u03b1\u03b2\u03b3 heterotrimeric G proteins coupled to specific transmembrane receptors known as G-protein coupled receptors. In-depth functional investigations revealed that this R200K mutation provides a gain of function to G\u03b1\n                    <jats:sub>13<\/jats:sub>\n                    . Mechanistically, we show that this variant hyperactivates the RHOA\/ROCK signalling pathway that consequently increases actin polymerisation and myosin light chains phosphorylation, and promotes melanocytes rounding. Our results also indicate that R200K G\u03b1\n                    <jats:sub>13<\/jats:sub>\n                    hyperactivates the YAP signalling pathway. All these changes appear to affect cell migration and adhesion but not the proliferation. Our results suggest that hypopigmentation can result from a defect in melanosome transfer to keratinocytes due to cell shape alterations. These findings highlight the interaction between heterotrimeric G proteins and the RHOA pathway, and their role in melanocyte function.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-56995-4","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:44:24Z","timestamp":1739893464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A postzygotic GNA13 variant upregulates the RHOA\/ROCK pathway and alters melanocyte function in a mosaic skin hypopigmentation syndrome"],"prefix":"10.1038","volume":"16","author":[{"given":"Rana","family":"El Masri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8053-2362","authenticated-orcid":false,"given":"Alberto","family":"Iannuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2814-6303","authenticated-orcid":false,"given":"Paul","family":"Kuentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachida","family":"Tacine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-5618","authenticated-orcid":false,"given":"Marie","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Barbarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Morice-Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Boralevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naia","family":"Oillarburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6259-9790","authenticated-orcid":false,"given":"Juliette","family":"Mazereeuw-Hautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis","family":"Duffourd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9770-444X","authenticated-orcid":false,"given":"Laurence","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8008-9145","authenticated-orcid":false,"given":"Arthur","family":"Sorlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Vabres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0222-1192","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Delon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"56995_CR1","doi-asserted-by":"publisher","first-page":"141S","DOI":"10.1038\/jid.1994.26","volume":"103","author":"VP Sybert","year":"1994","unstructured":"Sybert, V. P. Hypomelanosis of Ito: a description, not a diagnosis. J. Invest. Dermatol. 103, 141S\u2013143S (1994).","journal-title":"J. Invest. Dermatol."},{"key":"56995_CR2","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41436-021-01161-6","volume":"23","author":"V Carmignac","year":"2021","unstructured":"Carmignac, V. et al. Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities. Genet. Med. 23, 1484\u20131491 (2021).","journal-title":"Genet. Med."},{"key":"56995_CR3","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/s41588-019-0498-4","volume":"51","author":"P Vabres","year":"2019","unstructured":"Vabres, P. et al. Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome. Nat. Genet. 51, 1438\u20131441 (2019).","journal-title":"Nat. Genet."},{"key":"56995_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajhg.2020.11.013","volume":"108","author":"LG Biesecker","year":"2021","unstructured":"Biesecker, L. G. et al. A dyadic approach to the delineation of diagnostic entities in clinical genomics. Am. J. Hum. Genet. 108, 8\u201315 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"56995_CR5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1034\/j.1600-0749.2002.02056.x","volume":"15","author":"G Scott","year":"2002","unstructured":"Scott, G. Rac and rho: the story behind melanocyte dendrite formation. Pigment Cell Res 15, 322\u2013330 (2002).","journal-title":"Pigment Cell Res"},{"key":"56995_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.bi.56.070187.003151","volume":"56","author":"AG Gilman","year":"1987","unstructured":"Gilman, A. G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56, 615\u2013649 (1987).","journal-title":"Annu. Rev. Biochem."},{"key":"56995_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nrm2299","volume":"9","author":"WM Oldham","year":"2008","unstructured":"Oldham, W. M. & Hamm, H. E. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 9, 60\u201371 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"56995_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/bip.22836","volume":"105","author":"SR Sprang","year":"2016","unstructured":"Sprang, S. R. Invited review: Activation of G proteins by GTP and the mechanism of G\u03b1-catalyzed GTP hydrolysis. Biopolymers 105, 449\u2013462 (2016).","journal-title":"Biopolymers"},{"key":"56995_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1124\/mol.109.061234","volume":"77","author":"M Aittaleb","year":"2010","unstructured":"Aittaleb, M., Boguth, C. A. & Tesmer, J. J. G. Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors. Mol. Pharmacol. 77, 111\u2013125 (2010).","journal-title":"Mol. Pharmacol."},{"key":"56995_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41577-021-00500-7","volume":"21","author":"R El Masri","year":"2021","unstructured":"El Masri, R. & Delon, J. RHO GTPases: from new partners to complex immune syndromes. Nat. Rev. Immunol. 21, 499\u2013513 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"56995_CR11","doi-asserted-by":"publisher","first-page":"16897","DOI":"10.1074\/jbc.AC120.014698","volume":"295","author":"M Maziarz","year":"2020","unstructured":"Maziarz, M. et al. Naturally occurring hotspot cancer mutations in G\u03b113 promote oncogenic signaling. J. Biol. Chem. 295, 16897\u201316904 (2020).","journal-title":"J. Biol. Chem."},{"key":"56995_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/pcmr.13013","volume":"35","author":"JW Lui","year":"2022","unstructured":"Lui, J. W. et al. YAP facilitates melanoma migration through regulation of actin-related protein 2\/3 complex subunit 5 (ARPC5). Pigment Cell Melanoma Res 35, 52\u201365 (2022).","journal-title":"Pigment Cell Melanoma Res"},{"key":"56995_CR13","doi-asserted-by":"crossref","unstructured":"Moreiras, H., Seabra, M. C. & Barral, D. C. Melanin transfer in the epidermis: the pursuit of skin pigmentation control mechanisms. Int. J. Mol. Sci. 22, 4466 (2021).","DOI":"10.3390\/ijms22094466"},{"key":"56995_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2133.2004.06057.x","volume":"151","author":"SM Taibjee","year":"2004","unstructured":"Taibjee, S. M., Bennett, D. C. & Moss, C. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. Br. J. Dermatol. 151, 269\u2013282 (2004).","journal-title":"Br. J. Dermatol."},{"key":"56995_CR15","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962\u20131971 (2008).","journal-title":"Genes Dev."},{"key":"56995_CR16","doi-asserted-by":"publisher","first-page":"E2441","DOI":"10.1073\/pnas.1212021109","volume":"109","author":"JM Lamar","year":"2012","unstructured":"Lamar, J. M. et al. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc. Natl Acad. Sci. USA 109, E2441\u2013E2450 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56995_CR17","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato, F. et al. Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat. Cell Biol. 17, 1218\u20131227 (2015).","journal-title":"Nat. Cell Biol."},{"key":"56995_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/jid.2013.319","volume":"134","author":"F Nallet-Staub","year":"2014","unstructured":"Nallet-Staub, F. et al. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma. J. Invest. Dermatol. 134, 123\u2013132 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"56995_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/5584_2019_423","volume":"1237","author":"G Pennarossa","year":"2020","unstructured":"Pennarossa, G., Paffoni, A., Ragni, G., Gandolfi, F. & Brevini, T. A. L. Rho Signaling-Directed YAP\/TAZ Regulation Encourages 3D Spheroid Colony Formation and Boosts Plasticity of Parthenogenetic Stem Cells. Adv. Exp. Med. Biol. 1237, 49\u201360 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"56995_CR20","doi-asserted-by":"crossref","unstructured":"Mascharak, S. et al. Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring. Science 372, eaba2374 (2021).","DOI":"10.1126\/science.aba2374"},{"key":"56995_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature13765","volume":"516","author":"JR Muppidi","year":"2014","unstructured":"Muppidi, J. R. et al. Loss of signalling via G\u03b113 in germinal centre B-cell-derived lymphoma. Nature 516, 254\u2013258 (2014).","journal-title":"Nature"},{"key":"56995_CR22","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1038\/onc.2015.442","volume":"35","author":"M O\u2019Hayre","year":"2016","unstructured":"O\u2019Hayre, M. et al. Inactivating mutations in GNA13 and RHOA in Burkitt\u2019s lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the G\u03b113\/RhoA axis in B cells. Oncogene 35, 3771\u20133780 (2016).","journal-title":"Oncogene"},{"key":"56995_CR23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/cge.14410","volume":"104","author":"L Faivre","year":"2023","unstructured":"Faivre, L. et al. Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations. Clin. Genet. 104, 554\u2013563 (2023).","journal-title":"Clin. Genet."},{"key":"56995_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","volume":"457","author":"CD Van Raamsdonk","year":"2009","unstructured":"Van Raamsdonk, C. D. et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599\u2013602 (2009).","journal-title":"Nature"},{"key":"56995_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Van Raamsdonk","year":"2010","unstructured":"Van Raamsdonk, C. D. et al. Mutations in GNA11 in uveal melanoma. N. Engl. J. Med. 363, 2191\u20132199 (2010).","journal-title":"N. Engl. J. Med."},{"key":"56995_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ccr.2014.04.016","volume":"25","author":"X Feng","year":"2014","unstructured":"Feng, X. et al. Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell 25, 831\u2013845 (2014).","journal-title":"Cancer Cell"},{"key":"56995_CR27","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.jid.2019.08.455","volume":"140","author":"M Jordan","year":"2020","unstructured":"Jordan, M. et al. Reverse Phenotyping in Patients with Skin Capillary Malformations and Mosaic GNAQ or GNA11 Mutations Defines a Clinical Spectrum with Genotype-Phenotype Correlation. J. Invest. Dermatol. 140, 1106\u20131110.e2 (2020).","journal-title":"J. Invest. Dermatol."},{"key":"56995_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1365-2133.1994.tb02903.x","volume":"130","author":"E Rieger","year":"1994","unstructured":"Rieger, E. et al. Melanotic macules following Blaschko\u2019s lines in McCune-Albright syndrome. Br. J. Dermatol. 130, 215\u2013220 (1994).","journal-title":"Br. J. Dermatol."},{"key":"56995_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jbmr.4766","volume":"38","author":"KL Roszko","year":"2023","unstructured":"Roszko, K. L. et al. Identification of GNAS Variants in Circulating Cell-Free DNA from Patients with Fibrous Dysplasia\/McCune Albright Syndrome. J. Bone Miner. Res. 38, 443\u2013450 (2023).","journal-title":"J. Bone Miner. Res."},{"key":"56995_CR30","doi-asserted-by":"publisher","first-page":"e25143","DOI":"10.1371\/journal.pone.0025143","volume":"6","author":"M Zhang","year":"2011","unstructured":"Zhang, M. et al. Activin B promotes epithelial wound healing in vivo through RhoA-JNK signaling pathway. PLoS ONE 6, e25143 (2011).","journal-title":"PLoS ONE"},{"key":"56995_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1053\/gast.2002.34216","volume":"123","author":"RM Ray","year":"2002","unstructured":"Ray, R. M. et al. RhoA inactivation inhibits cell migration but does not mediate the effects of polyamine depletion. Gastroenterology 123, 196\u2013205 (2002).","journal-title":"Gastroenterology"},{"key":"56995_CR32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/gim.2016.220","volume":"19","author":"P Kuentz","year":"2017","unstructured":"Kuentz, P. et al. Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing. Genet. Med. 19, 989\u2013997 (2017).","journal-title":"Genet. Med."},{"key":"56995_CR33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cell.2020.06.020","volume":"182","author":"M Maziarz","year":"2020","unstructured":"Maziarz, M. et al. Revealing the Activity of Trimeric G-proteins in Live Cells with a Versatile Biosensor Design. Cell 182, 770\u2013785.e16 (2020).","journal-title":"Cell"},{"key":"56995_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/ni1039","volume":"5","author":"S Faure","year":"2004","unstructured":"Faure, S. et al. ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation. Nat. Immunol. 5, 272\u2013279 (2004).","journal-title":"Nat. Immunol."},{"key":"56995_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1021\/bi051729t","volume":"45","author":"B Kreutz","year":"2006","unstructured":"Kreutz, B. et al. A new approach to producing functional G alpha subunits yields the activated and deactivated structures of G alpha(12\/13) proteins. Biochemistry 45, 167\u2013174 (2006).","journal-title":"Biochemistry"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56995-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56995-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56995-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:44:26Z","timestamp":1739893466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56995-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56995"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56995-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"23 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1751"}}